Interactions between two enantiomers of losigamone and conventional antiepileptic drugs in the mouse maximal electroshock model - An isobolographic analysis

European Journal of Pharmacology

Volumn 567, Issue 1-2, 2007, Pages 110-116

  Borowicz, Kinga K ^a   Jaszczyk, Bozena ^a   Luszczki, Jarogniew J ^a   Czuczwar, Stanislaw J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; AO 242; AO 294; Drug interaction; Electroshock maximal; Isobolographic analysis

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LOSIGAMONE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; ELECTRIC SHOCK; ENANTIOMER; EPILEPSY; ISOBOLOGRAPHIC ANALYSIS; LONG TERM MEMORY; MALE; MEMORY DISORDER; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PHARMACODYNAMICS; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; AVOIDANCE LEARNING; BRAIN; CARBAMAZEPINE; DRUG INTERACTIONS; ELECTROSHOCK; FURANS; MALE; MEMORY; MICE; MOTOR ACTIVITY; PHENOBARBITAL; PHENYTOIN; SEIZURES; STEREOISOMERISM; VALPROIC ACID;

EID: 34249091026     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.04.002     Document Type: Article

References (25)

1. Berenbaum M.C. What is synergy?. Pharmacol. Rev. 41 (1989) 93-141
2. Bialer M., Johannessen S.I., Kupferberg H.J., Levy R.H., Loiseau P., and Perucca E. Progress report on new antiepileptic drugs: a summary of the fourth EILAT conference (EILAT IV). Epilepsy Res. 34 (1999) 1-41
3. Boissier J.R., Tardy J., and Diverres J.C. Une nouvelle methode simple pour explorer l'action tranquilisante: le test de la cheminee. Med. Exp. (Basel) 3 (1960) 81-84
4. Borowicz K.K., Malek R., Kimber-Trojnar Z., and Sobieszek G. Isobolographic analysis of the interactions of losigamone, remacemide, zonisamide with conventional antiepileptic drugs in the maximal electroshock test in mice - preliminary report. Neurol. Neurochir. Pol. 3 (2003) 35-36
5. Borowicz K.K., Jaszczyk B., and Czuczwar S.J. Isobolographic analysis of interactions among losigamone analog AO-620 and two conventional antiepileptic drugs. Pharmacol. Rep. 57 (2005) 236-240
6. Borowicz K.K., Kimber-Trojnar Z., Ratnaraj N., Patsalos P.N., Luszczki J., and Czuczwar S.J. Isobolographic analysis of interactions between losigamone and conventional antiepileptic drugs in the mouse maximal electroshock model. Eur. Neuropsychopharmacol. 17 (2007) 94-101
7. Czuczwar S.J., and Patsalos P.N. The new generation of GABA enhancers. CNS Drugs 15 (2001) 339-350
8. Czuczwar S.J., and Borowicz K.K. Polytherapy in epilepsy: the experimental evidence. Epilepsy Res. 52 (2002) 15-23
9. Deckers C.L.P., Czuczwar S.J., Hekster Y.A., Keyser A., Kubova H., Meinardi H., Patsalos P.N., Renier W.O., and Van Rijn C.M. Selection of antiepileptic drug Polytherapy based on mechanism of action: the evidence reviewed. Epilepsia 41 (2000) 1364-1374
10. Dimpfel W., Chatterje S.S., Noldner M., and Ticku M.K. Effects of the anticonvulsant losigamone and its isomers on GABA-receptor system. Epilepsia 36 (1995) 983-989
11. Gasior M., Ungard J.T., and Witkin J.M. Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J. Pharmacol. Exp. Ther. 290 (1999) 1148-1156
12. Greco W.R., Bravo G., and Parsons J.C. The search for synergy: a critical review from a response surface perspective. Pharmacol. Rev. 47 (1995) 331-385
13. Jones F.A., and Davies J.A. The anticonvulsant effects of the enantiomers of losigamone. Br. J. Pharmacol. 128 (1999) 1223-1228
14. Litchfield J.T., and Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96 (1949) 99-113
15. Loewe S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3 (1953) 285-290
16. Luszczki J.J., Borowicz K.K., Swiader M., and Czuczwar S.J. Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia 44 (2003) 489-499
17. Luszczki J.J., and Czuczwar S.J. Isobolographic characterization of interactions among selected newer antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model. Naunyn-Schmiedeberg's Arch. Pharmacol. 372 (2005) 41-54
18. Morris G.L., Collins S., and Bell W. Losigamone: a putative antiepileptic drug. J. Epilepsy 10 (1997) 62-66
19. Noldner M., and Chatterjee S.S. Losigamone. Drugs Future 15 (1990) 995-996
20. 5]enkephalin: a synergistic interaction. Eur. J. Pharmacol. 179 (1990) 463-468
21. Ragsdale D.S., and Avoli M. Sodium channels as molecular targets for antiepileptic drugs. Brain Res. Rev. 26 (1998) 16-28
22. Tallarida R.J. Drug synergism and dose-effect data analysis (2000), Chapman & Hall/CRC, Boca Raton
23. Tallarida R.J., Stone D.J., and Raffa R.B. Efficient designs for studying synergistic drug combinations. Life Sci. 61 (1997) PL417-PL425
24. Venault P., Chapouthier G., De Carvalho L.P., Simiand J., Morre M., Dodd R.H., and Rossier J. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks. Nature 321 (1986) 864-866
25. Zhang C.L., Chatterje S.S., Stein U., and Heineman U. Comparison of the effects of losigamone and its isomers on maximal electroshock induced convulsions in mice and on three different patterns of low magnesium induced epileptiform activity in slices of the rat temporal cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 345 (1992) 85-92